Table 1 Antibodies and probes used for immunohistochemical staining and in situ hybridization

From: Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios

Antibody or probe

Source

Clone

Dilution

Immunohistochemistry

B-cell markers

 CD20

Dako

L26

1:2400

 CD79a

Dako

JCB117

1:75

 PAX5

Biocare

BC/24

1:30

Germinal center and non-germinal center markers

 CD10

Novocastra

56C6

1:100

 BCL6

Novocastra

LN22

1:100

 MUM-1

Dako

MUM1p

1:200

 CD138

Dako

MI15

1:150

 BCL2

Dako

124

1:30

T-cell markers

 CD2

Novocastra

AB75

1:50

 CD3

Novocastra

PS1

1:150

 CD5

Novocastra

4C7

1:100

 CD7

Novocastra

CD7-272

1:75

 CD43

Biotest

MT1

1:600

Proliferation and activation markers

 Ki67

Dako

MIB1

1:250

 CD30

Dako

Ber-H2

1:30

Viral markers

 EBV-LMP1 (EBV latent membrane protein 1)

Dako

Cocktail of CS1-4

1:800

 EBNA-2 (EBV nuclear antigen 2)

Novocastra

PE2

1:50

 Human herpes virus 8

Novocastra

12B10

1:50

In situ hybridization

 EBER

Novocastra

Epstein–Barr virus probe (fluorescein conjugated)

NA

 Kappa light chain mRNA

Novocastra

Kappa Probe (fluorescein conjugated)

NA

 Lambda light chain mRNA

Novocastra

Lambda Probe (fluorescein conjugated)

NA

  1. Dako, Dako Corporation (Carpinteria, CA, USA).
  2. Biocare, Biocare Medical (Concord, CA, USA).
  3. Novocastra, Novocastra (Newcastle Upon Tyne, England, UK).
  4. Biotest, Clonab, Biotest Diagnostics (Dreieich, Germany).